Linked Life Data

8665721

Source:http://linkedlifedata.com/resource/pubmed/id/8665721

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1996-8-6
pubmed:abstractText
Twenty patients with recurrent nasal polyposis but without any history of aspirin sensitivity were given 2000 micrograms of intranasal lysine aspirin to one nostril and saline to the other once a week for periods of up to 15 months. Two patients had increased nasal obstruction following the initial test doses of lysine aspirin and were excluded from the trial proper. In the remainder symptomatic polyp recurrence was delayed compared with the previous experience while on intranasal steroids, with eight patients remaining symptom free at 15 months compared with an expected number of three (P = < 0.05, chi 2 test). Polyp recurrence was bilateral but there was a tendency for the lysine aspirin treated side to have less polyp tissue as assessed by nasendoscopy and by acoustic rhinometry.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0307-7772
pubmed:author
pubmed:issnType
Print
pubmed:volume
20
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
561-3
pubmed:dateRevised
2005-5-2
pubmed:meshHeading
pubmed:year
1995
pubmed:articleTitle
Intranasal lysine aspirin in recurrent nasal polyposis.
pubmed:affiliation
Royal National Throat, Nose and Ear Hospital NHS Trust, London, UK.
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial